MARINUS PHARMACEUTICALS INC financial statements, including revenue, expenses, profit, and loss
The total revenue of MRNS for the last quarter is 122.12 M MXN, and it's 4.52% lower compared to the previous quarter. The net income of Q4 23 is -709.45 M MXN.